144 related articles for article (PubMed ID: 15561903)
1. Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview.
Melander A
Diabetes; 2004 Dec; 53 Suppl 3():S151-5. PubMed ID: 15561903
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
Korytkowski MT
Pharmacotherapy; 2004 May; 24(5):606-20. PubMed ID: 15162895
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of sulfonylureas.
Melander A
Metabolism; 1987 Feb; 36(2 Suppl 1):12-6. PubMed ID: 3543616
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of glipizide.
Melander A; Wåhlin-Boll E
Am J Med; 1983 Nov; 75(5B):41-5. PubMed ID: 6424440
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms and Characteristics of Sulfonylureas and Glinides.
Lv W; Wang X; Xu Q; Lu W
Curr Top Med Chem; 2020; 20(1):37-56. PubMed ID: 31884929
[TBL] [Abstract][Full Text] [Related]
6. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
Lebovitz HE
Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454
[TBL] [Abstract][Full Text] [Related]
7. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
[TBL] [Abstract][Full Text] [Related]
8. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
[TBL] [Abstract][Full Text] [Related]
10. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
[TBL] [Abstract][Full Text] [Related]
11. Glyburide: a second-generation sulfonylurea hypoglycemic agent. History, chemistry, metabolism, pharmacokinetics, clinical use and adverse effects.
Feldman JM
Pharmacotherapy; 1985; 5(2):43-62. PubMed ID: 3923453
[TBL] [Abstract][Full Text] [Related]
12. Oral antidiabetic drugs: an overview.
Melander A
Diabet Med; 1996 Sep; 13(9 Suppl 6):S143-7. PubMed ID: 8894498
[TBL] [Abstract][Full Text] [Related]
13. Insulin responses to sulfonylureas.
Cerasi E
Diabetes Res Clin Pract; 2002 Apr; 56(1):69-70; author reply 71. PubMed ID: 11879723
[No Abstract] [Full Text] [Related]
14. Longitudinal evaluation of the effects of sulfonylurea therapy in subjects with type II diabetes mellitus.
Kolterman OG
Am J Med; 1985 Sep; 79(3B):23-33. PubMed ID: 3931459
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus.
Owens DR
Am J Med; 1985 Aug; 79(2B):27-32. PubMed ID: 3929599
[TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia in hospitalized patients treated with sulfonylureas.
Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
[TBL] [Abstract][Full Text] [Related]
17. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
18. Sulfonylureas. Why, which, and how?
Melander A; Lebovitz HE; Faber OK
Diabetes Care; 1990 Aug; 13 Suppl 3():18-25. PubMed ID: 2209339
[TBL] [Abstract][Full Text] [Related]
19. Use of sulfonylurea agents in older diabetic patients.
Peters AL; Davidson MB
Clin Geriatr Med; 1990 Nov; 6(4):903-21. PubMed ID: 2224754
[TBL] [Abstract][Full Text] [Related]
20. Impaired effect of sulfonylurea following increased dosage.
Wåhlin-Boll E; Sartor G; Melander A; Scherstén B
Eur J Clin Pharmacol; 1982; 22(1):21-5. PubMed ID: 7047168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
